PPP1R16B and breast carcinoma: This finding further highlights the potential role of TIMAP as a therapeutic target and, thus, we recommend future investigations to address the molecular mechanism of this protein in breast cancer development and the possibility of targeting it in the treatment of this disease, especially in drug resistant subtypes.